1298 related articles for article (PubMed ID: 33770348)
1. The Role of Mucosal Immunity and Recombinant Probiotics in SARS-CoV2 Vaccine Development.
Moradi-Kalbolandi S; Majidzadeh-A K; Abdolvahab MH; Jalili N; Farahmand L
Probiotics Antimicrob Proteins; 2021 Oct; 13(5):1239-1253. PubMed ID: 33770348
[TBL] [Abstract][Full Text] [Related]
2. Intranasal COVID-19 vaccines: From bench to bed.
Alu A; Chen L; Lei H; Wei Y; Tian X; Wei X
EBioMedicine; 2022 Feb; 76():103841. PubMed ID: 35085851
[TBL] [Abstract][Full Text] [Related]
3. Safety, mucosal and systemic immunopotency of an aerosolized adenovirus-vectored vaccine against SARS-CoV-2 in rhesus macaques.
Xu F; Wu S; Yi L; Peng S; Wang F; Si W; Hou L; Zhu T
Emerg Microbes Infect; 2022 Dec; 11(1):438-441. PubMed ID: 35094672
[TBL] [Abstract][Full Text] [Related]
4. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
5. Prospects for mucosal vaccine: shutting the door on SARS-CoV-2.
Mudgal R; Nehul S; Tomar S
Hum Vaccin Immunother; 2020 Dec; 16(12):2921-2931. PubMed ID: 32931361
[TBL] [Abstract][Full Text] [Related]
6. Essential considerations during vaccine design against COVID-19 and review of pioneering vaccine candidate platforms.
Bayat M; Asemani Y; Najafi S
Int Immunopharmacol; 2021 Aug; 97():107679. PubMed ID: 33930707
[TBL] [Abstract][Full Text] [Related]
7. Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection.
Nagai M; Moriyama M; Ichinohe T
mBio; 2021 Aug; 12(4):e0159821. PubMed ID: 34399617
[TBL] [Abstract][Full Text] [Related]
8. Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2.
Afkhami S; D'Agostino MR; Zhang A; Stacey HD; Marzok A; Kang A; Singh R; Bavananthasivam J; Ye G; Luo X; Wang F; Ang JC; Zganiacz A; Sankar U; Kazhdan N; Koenig JFE; Phelps A; Gameiro SF; Tang S; Jordana M; Wan Y; Mossman KL; Jeyanathan M; Gillgrass A; Medina MFC; Smaill F; Lichty BD; Miller MS; Xing Z
Cell; 2022 Mar; 185(5):896-915.e19. PubMed ID: 35180381
[TBL] [Abstract][Full Text] [Related]
9. Peritoneal Administration of a Subunit Vaccine Encapsulated in a Nanodelivery System Not Only Augments Systemic Responses against SARS-CoV-2 but Also Stimulates Responses in the Respiratory Tract.
Jearanaiwitayakul T; Apichirapokey S; Chawengkirttikul R; Limthongkul J; Seesen M; Jakaew P; Trisiriwanich S; Sapsutthipas S; Sunintaboon P; Ubol S
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835008
[TBL] [Abstract][Full Text] [Related]
10. Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines.
Zhang Y; Banga Ndzouboukou JL; Gan M; Lin X; Fan X
Front Immunol; 2021; 12():771242. PubMed ID: 34880867
[TBL] [Abstract][Full Text] [Related]
11. DNA vaccines against COVID-19: Perspectives and challenges.
Silveira MM; Moreira GMSG; Mendonça M
Life Sci; 2021 Feb; 267():118919. PubMed ID: 33352173
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 vaccinations: The unknowns, challenges, and hopes.
Mohamed K; Rzymski P; Islam MS; Makuku R; Mushtaq A; Khan A; Ivanovska M; Makka SA; Hashem F; Marquez L; Cseprekal O; Filgueiras IS; Fonseca DLM; Mickael E; Ling I; Arero AG; Cuschieri S; Minakova K; Rodríguez-Román E; Abarikwu SO; Faten AB; Grancini G; Cabral-Marques O; Rezaei N
J Med Virol; 2022 Apr; 94(4):1336-1349. PubMed ID: 34845731
[TBL] [Abstract][Full Text] [Related]
13. The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity.
Del Fresno C; García-Arriaza J; Martínez-Cano S; Heras-Murillo I; Jarit-Cabanillas A; Amores-Iniesta J; Brandi P; Dunphy G; Suay-Corredera C; Pricolo MR; Vicente N; López-Perrote A; Cabezudo S; González-Corpas A; Llorca O; Alegre-Cebollada J; Garaigorta U; Gastaminza P; Esteban M; Sancho D
Front Immunol; 2021; 12():748103. PubMed ID: 34867974
[TBL] [Abstract][Full Text] [Related]
14. The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines.
Chan RWY; Liu S; Cheung JY; Tsun JGS; Chan KC; Chan KYY; Fung GPG; Li AM; Lam HS
Front Immunol; 2021; 12():744887. PubMed ID: 34712232
[TBL] [Abstract][Full Text] [Related]
15. Audio Interview: Aspects of Covid-19 Immunity.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2021 Aug; 385(8):e31. PubMed ID: 34407350
[No Abstract] [Full Text] [Related]
16. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
Elife; 2022 Feb; 11():. PubMed ID: 35191378
[TBL] [Abstract][Full Text] [Related]
17. A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 Vaccine.
Zhu J; Jain S; Sha J; Batra H; Ananthaswamy N; Kilgore PB; Hendrix EK; Hosakote YM; Wu X; Olano JP; Kayode A; Galindo CL; Banga S; Drelich A; Tat V; Tseng CK; Chopra AK; Rao VB
mBio; 2022 Aug; 13(4):e0182222. PubMed ID: 35900097
[TBL] [Abstract][Full Text] [Related]
18. A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine.
Hörner C; Schürmann C; Auste A; Ebenig A; Muraleedharan S; Dinnon KH; Scholz T; Herrmann M; Schnierle BS; Baric RS; Mühlebach MD
Proc Natl Acad Sci U S A; 2020 Dec; 117(51):32657-32666. PubMed ID: 33257540
[TBL] [Abstract][Full Text] [Related]
19. Toll-like Receptor-4 (TLR4) Agonist-Based Intranasal Nanovaccine Delivery System for Inducing Systemic and Mucosal Immunity.
Bakkari MA; Valiveti CK; Kaushik RS; Tummala H
Mol Pharm; 2021 Jun; 18(6):2233-2241. PubMed ID: 34010002
[TBL] [Abstract][Full Text] [Related]
20. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.
Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y
Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]